Soleo health to administer alnylam pharmaceuticals' givlaari® (givosiran) for the treatment of acute hepatic porphyria in adults

Frisco, texas--(business wire)-- #soleohealhtotreatahpwithgivlaari--soleo health to administer alnylam pharmaceuticals' givlaari® (givosiran) for the treatment of acute hepatic porphyria in adults
ALNY Ratings Summary
ALNY Quant Ranking